1315 Capital has acquired the Life Sciences and Diagnostics (LSDx) division of Argonaut Manufacturing Services, according to a news release.
The LSDx business will operate independently as Aluris Sciences. Aluris is a contract manufacturing partner providing manufacturing solutions for life sciences, diagnostics and combination drug product customers.
1315 Capital, founded in 2014…
Eir Partners has acquired Accumulus Technologies, according to a news release.
Accumulus, founded in 2025 as a spinout of Accumulus Synergy and based in San Francisco, is a software-as-a-service company whose cloud platform enables life sciences organizations and global regulatory authorities to exchange data and collaborate on submissions.
Eir, founded in 2015…
H.I.G. Capital recently announced that one of its affiliates had completed the acquisition of Outcomes One.
Outcomes, founded in 1977 and based in Orlando, Florida, is a provider of clinical network services and pharmacy technology.
H.I.G., founded in 1993 and based in Miami, pursues a wide range of investments in healthcare and many…
Thurston Group has acquired Pixel Health, according to a news release and a company announcement.
Pixel Health, founded in 2001 and based in Holyoke, Massachusetts, provides IT consulting and managed IT services to hospitals and large physician groups.
Thurston, founded in 1986 and based in Chicago, is a private equity firm focused…
BPOC recently announced strategic investments in Master Medical Equipment (MME) and ReNew Biomedical.
MME, founded in 2011 and based in Jackson, Tennessee, is a provider of EMS capital equipment, rentals and service.
ReNew, founded in 2014 and based in Jackson, Tennessee, services, repairs and maintains defibrillators, ventilators, infusion pumps, AEDs, ECGs and vital…
On September 18, 2026, the Department of Justice (DOJ or the Department) announced two significant revisions to the Justice Manual that aim to reshape False Claims Act (FCA) enforcement. The first revision reinstates and expands the Department’s 2017 policy limiting the use of sub-regulatory guidance documents in enforcement actions by restricting the government’s ability to treat agency guidance as binding legal authority. The second revision strengthens the Department’s approach to dismissing qui tam actions filed by private relators, directing attorneys to assess whether dismissal is warranted in every declined case. Together, these changes signal a more disciplined enforcement posture, suggesting that the Department intends to pursue fraud cases grounded in clear legal obligations while more actively culling meritless whistleblower suits.
Associate Attorney General Stanley E. Woodward, Jr. framed the revisions in terms of regulatory restraint: “The Department of Justice should enforce the law, not make law through enforcement. These updates reflect the Department’s commitment to fair notice, transparent enforcement, and the rule of law.”
Flexpoint Ford recently announced it sold ArtesRx to Linden Capital Partners.
ArtesRx, established in 2023 by Flexpoint and Dom Meffe, is a behavioral health pharmacy platform serving individuals who depend on complex medication regimens.
Flexpoint, founded in 2005 and based in Chicago, invests in the healthcare business and financial solutions and other sectors.…
“Surveillance pricing” describes the use of formulas, software or AI to set prices dynamically when those systems incorporate personal information (e.g., browsing history, purchase patterns, demographic profiles, device identifiers or inferred willingness to pay) to tailor prices to individual consumers. This practice is distinct from broader “algorithmic pricing,” which relies on market-wide inputs such as…
SaaS is dead in the age of AI, say many in healthcare software.
Not so fast, says Noah Lewis, managing partner at Ardan Equity, a sector specialist at the intersection of healthcare, life sciences and technology. Arguing that the “SaaSpocalypse” is overblown, he joins McGuireWoods partner and host Geoff Cockrell to discuss…
On September 1, 2026, the U.S. Department of Justice (“DOJ”) announced a $2,042,518 False Claims Act (“FCA”) settlement with Honeywell Aerospace Inc. (“Honeywell Aerospace” or “Honeywell” or “the company”), resolving allegations that the company failed to comply with certain cybersecurity requirements in a contract with the U.S. Department of War (“DoW”). This settlement is the latest in a growing line of enforcement actions under DOJ’s Civil Cyber-Fraud Initiative and underscores the government’s continued willingness to use the FCA to hold defense contractors accountable for apparent failures to comply with cybersecurity-related requirements.
